Covered recipient · General Payments record
GEORGE CRAIG SHAPIRO
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$9,515.93
- Reported across 328 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $605.48 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $317.18 | 10 |
| Novo Nordisk AS | $122.90 | 1 |
| BAXTER HEALTHCARE | $50.70 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.73 | 2 |
| Lilly USA, LLC | $25.71 | 1 |
| Cleerly, Inc. | $25.42 | 1 |
| United Therapeutics Corporation | $16.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.41 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073306 | CMS |
| ABBVIE INC. | $32.07 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073308 | CMS |
| ABBVIE INC. | $31.12 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073310 | CMS |
| ABBVIE INC. | $34.46 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073312 | CMS |
| ABBVIE INC. | $34.46 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073314 | CMS |
| ABBVIE INC. | $22.29 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073316 | CMS |
| ABBVIE INC. | $32.78 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073318 | CMS |
| ABBVIE INC. | $30.85 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073320 | CMS |
| ABBVIE INC. | $33.63 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073322 | CMS |
| ABBVIE INC. | $31.11 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106073324 | CMS |
| Baxter Healthcare | $50.70 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120650707 | CMS |
| Cleerly, Inc. | $25.42 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144711570 | CMS |
| Lilly USA, LLC | $25.71 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134985630 | CMS |
| Novartis Pharmaceuticals Corporation | $23.97 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087261567 | CMS |
| Novartis Pharmaceuticals Corporation | $22.76 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087261581 | CMS |
| Novo Nordisk Inc | $122.90 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096590907 | CMS |
| United Therapeutics Corporation | $16.84 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149452356 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.